Ung Gu Kang, Se Hyun Kim, Young Sook Choi, Kyu Young Lee, Yong Sik Kim & In Won Chung. (2023) Practical Issues With Clonazepam Use. Journal of Korean Neuropsychiatric Association 62:1, pages 21.
Crossref
Zui Narita, Michiko Fujimoto, Elizabeth Winter, Paul Nestadt & Akira Sawa. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
68
.
Theodore FlaumDO, FACOFPDO, FACOFP, Ravi ChinskyOMS0IIIOMS0III & Sheldon YaoDODO. (2020) Obsessive-Compulsive Disorder: Diagnosis and Management with an Osteopathic Component. Osteopathic Family Physician, pages 18-24.
Crossref
Pankaj Vinod Dixit, Rohit Sahu & Dinesh Kumar Mishra. (2020) Marble-burying behavior test as a murine model of compulsive-like behavior. Journal of Pharmacological and Toxicological Methods 102, pages 106676.
Crossref
Georgios D. Kotzalidis, Antonio Del Casale, Maurizio Simmaco, Lucia Pancheri, Roberto Brugnoli, Marco Paolini, Ida Gualtieri, Stefano Ferracuti, Valeria Savoja, Ilaria Cuomo, Lavinia De Chiara, Alessio Mosca, Gabriele Sani, Paolo Girardi, Maurizio Pompili & Chiara Rapinesi. (2019) Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time. Current Neuropharmacology 17:8, pages 741-774.
Crossref
Antonio Del Casale, Serena Sorice, Alessio Padovano, Maurizio Simmaco, Stefano Ferracuti, Dorian A. Lamis, Chiara Rapinesi, Gabriele Sani, Paolo Girardi, Georgios D. Kotzalidis & Maurizio Pompili. (2019) Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Current Neuropharmacology 17:8, pages 710-736.
Crossref
Ricky A. Sachdev, Risha Ruparelia, Jemma E. Reid, Davis Mpavenda, Eduardo Cinosi & Naomi A. Fineberg. 2018. A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena. A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena
183
206
.
Luana D. Laurito, Carla P. Loureiro, Rafaela V. Dias, Paula Vigne, Gabriela B. de Menezes, Rafael C. Freire, Ulrich Stangier & Leonardo F. Fontenelle. (2018) Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients. Psychiatry Research 262, pages 237-245.
Crossref
Tord Ivarsson, Gudmundur Skarphedinsson & Bernhard Weidle. 2018. The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-compulsive Disorder. The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-compulsive Disorder
155
183
.
M. Todd Sewell, Nicholas D. Wignall & Bradford C. Richards. 2018. Principle-Based Stepped Care and Brief Psychotherapy for Integrated Care Settings. Principle-Based Stepped Care and Brief Psychotherapy for Integrated Care Settings
279
288
.
Mark D. Muse & Stephen M. Stahl. 2017. Cognitive Behavioral Psychopharmacology. Cognitive Behavioral Psychopharmacology
107
135
.
S. Evelyn Stewart & Adrian S. Loh. 2017. The Wiley Handbook of Obsessive Compulsive Disorders. The Wiley Handbook of Obsessive Compulsive Disorders
261
282
.
C. M. Gillan, N. A. Fineberg & T. W. Robbins. (2017) A trans-diagnostic perspective on obsessive-compulsive disorder. Psychological Medicine 47:9, pages 1528-1548.
Crossref
Murad Atmaca. (2016) Treatment-refractory obsessive compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 127-133.
Crossref
Christine Poppe, Sabrina T. Müller, Waldemar Greil, Alice Walder, Renate Grohmann & Susanne Stübner. (2016) Pharmacotherapy for obsessive compulsive disorder in clinical practice – Data of 842 inpatients from the International AMSP Project between 1994 and 2012. Journal of Affective Disorders 200, pages 89-96.
Crossref
Claire M. Gillan, Trevor W. Robbins, Barbara J. Sahakian, Odile A. van den Heuvel & Guido van Wingen. (2016) The role of habit in compulsivity. European Neuropsychopharmacology 26:5, pages 828-840.
Crossref
Firoz Kazhungil & E Mohandas. (2016) Management of obsessive-compulsive disorder comorbid with bipolar disorder. Indian Journal of Psychiatry 58:3, pages 259.
Crossref
Vladan Starcevic, David Berle, Maria Conceição do Rosário, Vlasios Brakoulias, Ygor A. Ferrão, Kirupamani Viswasam, Roseli Shavitt, Euripedes Miguel & Leonardo F. Fontenelle. (2016) Use of benzodiazepines in obsessive–compulsive disorder. International Clinical Psychopharmacology 31:1, pages 27-33.
Crossref
Matthew A. Fuller. 2016. The Medical Basis of Psychiatry. The Medical Basis of Psychiatry
707
780
.
Gudmundur Skarphedinsson & Tord Ivarsson. (2015) Evidence-Based Treatments in Treatment-Naïve and Treatment-Resistant Pediatric Obsessive-Compulsive Disorder. Current Behavioral Neuroscience Reports 2:3, pages 127-136.
Crossref
Xenia Borue, Mehak Sharma & Robert Hudak. (2015) Biological treatments for obsessive-compulsive and related disorders. Journal of Obsessive-Compulsive and Related Disorders 6, pages 7-26.
Crossref
Michael H. Bloch & Eric A. Storch. (2015) Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children. Journal of the American Academy of Child & Adolescent Psychiatry 54:4, pages 251-262.
Crossref
Joanna E. Steinglass, Simona C. Kaplan, Ying Liu, Yuanjia Wang & B. Timothy Walsh. (2014) The (lack of) effect of alprazolam on eating behavior in anorexia nervosa: A preliminary report. International Journal of Eating Disorders 47:8, pages 901-904.
Crossref
Deborah Ducasse, Laurent Boyer, Pierre Michel, Anderson Loundou, Alexandra Macgregor, Jean-Arthur Micoulaud-Franchi, Philippe Courtet, Mocrane Abbar, Marion Leboyer & Guillaume Fond. (2014) D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis. Psychopharmacology 231:18, pages 3765-3770.
Crossref
Somnath Mondal, Indranil Saha, Saibal Das, Abhrajit Ganguly, Debasis Das & Santanu Kumar Tripathi. (2013) A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case series. Therapeutic Advances in Psychopharmacology 3:6, pages 322-334.
Crossref
Deborah S. Kreiss, Catherine F. Coffman, Nicholas R. Fiacco, Jason C. Granger, Bernadette M. Helton, Jennifer C. Jackson, Leonid V. Kim, Rishi S. Mistry, Tammie M. Mizer, Lolita V. Palmer, Jay A. Vacca, Stuart S. Winkler & Benjamin A. Zimmer. (2013) Ritualistic Chewing Behavior induced by mCPP in the rat is an animal model of Obsessive Compulsive Disorder. Pharmacology Biochemistry and Behavior 104, pages 119-124.
Crossref
Naomi A Fineberg, Samar Reghunandanan, Angus Brown & Ilenia Pampaloni. (2012) Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond. Australian & New Zealand Journal of Psychiatry 47:2, pages 121-141.
Crossref
Max Fink. (2013) Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatrica Scandinavica 127, pages 1-47.
Crossref
B. Dell’osso & M. Lader. (2013) Do Benzodiazepines Still Deserve a Major Role in The Treatment of Psychiatric Disorders? A Critical Reappraisal. European Psychiatry 28:1, pages 7-20.
Crossref
Naomi A. Fineberg, Angus Brown & Ilenia Pampaloni. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
128
170
.
Mathew L. Nguyen, Michael A. Shapiro & Stephen J. Welch. (2012) A case of severe adolescent obsessive-compulsive disorder treated with inpatient hospitalization, risperidone and sertraline. Journal of Behavioral Addictions 1:2, pages 78-82.
Crossref
Dan J. Stein, Nastassja Koen, Naomi Fineberg, Leonardo F. Fontenelle, Hisato Matsunaga, David Osser & H. Blair Simpson. (2012) A 2012 Evidence-Based Algorithm for the Pharmacotherapy for Obsessive-Compulsive Disorder. Current Psychiatry Reports 14:3, pages 211-219.
Crossref
S. Evelyn Stewart, Dianne Hezel & Andrea C. Stachon. (2012) Assessment and Medication Management of Paediatric Obsessive-Compulsive Disorder. Drugs 72:7, pages 881-893.
Crossref
Simran K. Kalra & Susan E. Swedo. (2009) Children with obsessive-compulsive disorder: are they just “little adults”?. Journal of Clinical Investigation 119:4, pages 737-746.
Crossref
Li Wang, Helen B. Simpson & Stephanie C. Dulawa. (2009) Assessing the validity of current mouse genetic models of obsessive–compulsive disorder. Behavioural Pharmacology 20:2, pages 119-133.
Crossref
Chi-Un Pae & Ashwin A. Patkar. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
769
785
.
Darin D. Dougherty & Michael A. Jenike. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
753
758
.
Panagiotis Oulis, Andreas Florakis, George Tzanoulinos & George N. Papadimitriou. (2008) Pregabalin in the treatment of benzodiazepine-induced obsessive–compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:8, pages 2000-2001.
Crossref
Paul J. Perry, Heidi J. Wehring, Bruce Alexander & Barry Liskow. 2008. The Medical Basis of Psychiatry. The Medical Basis of Psychiatry
577
634
.
Judith L. Rapoport & Gale Inoff‐Germain. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
. 2007. Les traitements du trouble obsessionnel compulsif. Les traitements du trouble obsessionnel compulsif
71
87
.
Damiaan Denys. (2006) Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum Disorders. Psychiatric Clinics of North America 29:2, pages 553-584.
Crossref
Antonio E. Nardi & Giampaolo Perna. (2006) Clonazepam in the treatment of psychiatric disorders: an update. International Clinical Psychopharmacology 21:3, pages 131-142.
Crossref
Naomi A. FinebergTim M. Gale & Thanusha Sivakumaran. (2005) A review of antipsychotics in the treatment of obsessive compulsive disorder. Journal of Psychopharmacology 20:1, pages 97-103.
Crossref
Leonardo F. Fontenelle, Mauro V. Mendlowicz, Juliana Kalaf, Aline M. Domingues & Marcio Versiani. (2005) Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive???compulsive disorder?. International Clinical Psychopharmacology 20:6, pages 343-346.
Crossref